From Earlier: D.A. Davidson Reiterates USANA Health Sciences Buy, Raises PT

D.A. Davidson reiterated its USANA Health Sciences

Buy rating and raised its price target from $46 to $51 in a research report published today. In the report, D.A. Davidson stated, "While North America remains a drag, we are enthusiastic about the business environment and growth opportunities for USANA in Asia. The company ended the quarter with $71 million in cash and no debt." Shares of USANA Health Sciences closed today at $36.80, up 0.22% from Monday's market close.